trending Market Intelligence /marketintelligence/en/news-insights/trending/qks7L_1sTdLwMQ2391auJg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Sanofi expands French vaccine production site

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Sanofi expands French vaccine production site

Sanofi is investing €170 million to expand a vaccine manufacturing site in Val de Reuil, France.

The new facility will allow Sanofi's vaccines unit, Sanofi Pasteur, to expand the supply of influenza vaccine VaxigripTetra, which is compliant with the World Health Organization's recommendation.

Sanofi plans to complete the expansion by 2021, subject to regulatory approvals, and will commence vaccine production in the new facility in 2022.

Sanofi Pasteur remains the sole influenza vaccine producer in France.